NCT05665257

Brief Summary

The goal of this randomized controlled feasibility study was to evaluate the feasibility of preoperative inspiratory muscle training in patients undergoing surgery because of peritoneal metastases. The main questions it aimed to answer was how feasible the intervention is regarding process and scientific feasibility as defined by Thabane et al 2010. Participants in the intervention group were using a handheld device to increase their inspiratory muscle strength prior to surgery and researchers compared this group to a control group who were offered a sham treatment.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2016

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2016

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2020

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

December 5, 2022

Completed
22 days until next milestone

First Posted

Study publicly available on registry

December 27, 2022

Completed
Last Updated

December 27, 2022

Status Verified

December 1, 2022

Enrollment Period

3.8 years

First QC Date

December 5, 2022

Last Update Submit

December 16, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Feasibility of preoperative inspiratory muscle training

    Feasibility will be assessed using two domains: process and scientific feasibility. These domains include several parts such as recruitment rates, time available for training, intervention adherence, patient acceptability, pre-and postoperative respiratory muscle and lung function assessments, reproducibility of assessments, preliminary treatment effect, incidence of PPCs, and adverse events.

    The different outcome measures are assessed continuously during a period from inclusion until discharge from the hospital. This period varied in length (3 weeks-3 months) depending on when participants were scheduled for surgery.

Study Arms (2)

Inspiratory muscle training

EXPERIMENTAL

Participants in the intervention group were using a handheld device, Powerbreathe K3, aiming at increasing inspiratory muscle strength by applying an inspiratory resistance. They were instructed to use it twice a day for at least 14 days. Starting load was based on the baseline assessment of the participant's inspiratory muscle strength and increased during the intervention period.

Device: Inspiratory muscle training

Mini-PEP

SHAM COMPARATOR

Participants in the control arm were instructed to use a handheld PEP-device traditionally used to facilitate deep breathing. The PEP-device does not provide any inspiratory resistance and therefore, it was considered a sham treatment. The control group were also instructed to use the device twice a day for at least two weeks.

Device: Mini-PEP

Interventions

Inspiratory muscle training
Mini-PEPDEVICE
Mini-PEP

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Scheduled for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

You may not qualify if:

  • Inability to speak and understand Swedish

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Mikael Andersson, PhD

    Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 5, 2022

First Posted

December 27, 2022

Study Start

November 1, 2016

Primary Completion

September 1, 2020

Study Completion

September 1, 2020

Last Updated

December 27, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will share

De-identified data will be shared upon reasonable request.